1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nifedipine in 13 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 16,024 | 2,496 | 1,505 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pugsley, MK; Salari, H; Walker, MJ | 1 |
| Gandhi, CR; Olson, MS | 1 |
| Bazill, GW; Dexter, TM | 1 |
| Bevan, J; Heptinstall, S | 1 |
| Bevan, J; Glusa, E; Heptinstall, S | 1 |
| Braquet, P; Chabrier, PE; Lagente, V; Mencia-Huerta, JM | 1 |
| Knee, CD; Krell, RD; Kusner, EJ | 1 |
| Lad, N; Lunt, DO; McCullagh, KG; Tuffin, DP; Wade, PJ | 1 |
| Clark, JS; Jubb, SN; Maloney, PJ; Young, JM | 1 |
| Benveniste, J; Cerrina, J; Coëffier, E; Duroux, P; Jouvin-Marche, E | 1 |
| Endo, C; Hoshi, K; Nakanishi, H; Okawa, T; Sato, A; Suzuki, H; Suzuki, Y | 1 |
| Durán, WN; Hobson, RW; Kim, D; Kobayashi, I; Oshiro, H; Takenaka, H | 1 |
| James, AN; Parkman, HP; Ryan, JP | 1 |
13 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nifedipine
| Article | Year |
|---|---|
Actions of platelet-activating factor on isolated rat hearts.
Topics: Animals; Blood Flow Velocity; Dose-Response Relationship, Drug; Electrocardiography; Heart; Male; Myocardial Contraction; Nifedipine; Perfusion; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrodotoxin | 1991 |
PAF effects on transmembrane signaling pathways in rat Kupffer cells.
Topics: Animals; Bradykinin; Calcium; Cell Membrane; Cells, Cultured; Cholera Toxin; Egtazic Acid; Inositol Phosphates; Kupffer Cells; Liver; Male; Models, Biological; Nifedipine; Norepinephrine; Pertussis Toxin; Phosphatidylinositols; Platelet Activating Factor; Prostaglandins; Rats; Rats, Inbred Strains; Signal Transduction; Vasopressins; Virulence Factors, Bordetella | 1991 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amlodipine; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Verapamil | 1988 |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Topics: Adenosine Diphosphate; Amlodipine; Calcium Channel Blockers; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1989 |
Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig.
Topics: Aerosols; Animals; Blood Pressure; Bronchi; Diterpenes; Endothelins; Endothelium, Vascular; Ginkgolides; Guinea Pigs; Indomethacin; Lactones; Male; Nifedipine; Peptides; Plant Extracts; Platelet Activating Factor; Propranolol; Pyrilamine; Verapamil | 1989 |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat.
Topics: Animals; Capillary Permeability; Chromones; Dose-Response Relationship, Drug; Indomethacin; Masoprocol; Methysergide; Nifedipine; Phenoxybenzamine; Phospholipid Ethers; Platelet Activating Factor; Pyrilamine; Rats; Theophylline; Thiazoles | 1987 |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Topics: Benzazepines; Blood Platelets; Buffers; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Male; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Statistics as Topic; Stereoisomerism; Tritium; Verapamil | 1986 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
Topics: Anaphylaxis; Animals; Chloroquine; Chlortetracycline; Dexamethasone; Dose-Response Relationship, Drug; Female; Indomethacin; Injections, Intravenous; Male; Mice; Mice, Inbred DBA; Naproxen; Nicardipine; Nifedipine; Platelet Activating Factor; Pyrazoles; Quinacrine; Tetracycline; Verapamil | 1985 |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils.
Topics: Autacoids; Calcium; Calcium Channel Blockers; Glucuronidase; Humans; In Vitro Techniques; Neutrophils; Nifedipine; Platelet Activating Factor; Pyridines | 1983 |
[Endothelin-1-induced contraction of pregnant rat myometrium: role of platelet-activating factor].
Topics: Animals; Dose-Response Relationship, Drug; Endothelins; Female; In Vitro Techniques; Indomethacin; Isoquinolines; Nifedipine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pregnancy; Pyridinium Compounds; Rats; Tetrahydroisoquinolines; Uterine Contraction | 1994 |
L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nifedipine; Platelet Activating Factor; Spectrometry, Fluorescence; Vasoconstriction; Verapamil | 1995 |
The contractile action of platelet-activating factor on gallbladder smooth muscle.
Topics: Acetylcholine; Animals; Calcium; Calcium Channel Blockers; Diterpenes; Dose-Response Relationship, Drug; Free Radical Scavengers; Gallbladder Emptying; Ginkgolides; Guinea Pigs; In Vitro Techniques; Lactones; Muscle Contraction; Muscle, Smooth; Nifedipine; Pertussis Toxin; Platelet Activating Factor; Prostaglandins; Ryanodine; Vasodilator Agents; Virulence Factors, Bordetella | 2000 |